Merck KGaA, Darmstadt, Germany, has agreed to acquire Bio-Techne Corporation (NASDAQ: TECH) for $73 per share in cash, representing a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE